Sedative-hypnotic drugs: interaction with calcium channels.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001569:Benzodiazepines; D001921:Brain / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism*; D000431:Ethanol / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007473:Ion Channels / Q000187:drug effects*; D009474:Neurons / Q000187:drug effects; D051381:Rats; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D013570:Synaptic Membranes / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects; D013574:Synaptosomes / Q000187:drug effects
D014151:Anti-Anxiety Agents; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D007473:Ion Channels; D017981:Receptors, Neurotransmitter; D001569:Benzodiazepines; D000431:Ethanol; D002118:Calcium